肥胖对腹膜透析患者模式维持、残余肾功能、腹膜炎及生存的影响
本研究为历史性队列研究,纳入2007-2011年美国大型透析机构的15,573例新发腹膜透析患者,分析体重指数(BMI)与模式维持、残余肾功能、腹膜炎及生存的关系。结果显示较高BMI与更早转血液透析、更晚接受肾移植、残余肾功能下降更快相关,BMI与死亡率呈U形关联,BMI 30-<35 kg/m2生存最佳;与匹配的血透患者相比,肥胖腹透患者生存不劣于血透。
要点
- 较高BMI与腹透转血透风险增加、残余肾功能下降更快相关。
- BMI与死亡率呈U形关联,BMI 30-<35 kg/m2生存最佳。
- 重度肥胖腹透患者生存与匹配血透患者相当。
核心结论
- 肥胖腹膜透析患者并发症风险高于非肥胖患者,但生存不劣于匹配的血液透析患者。
研究设计与样本
- 历史性队列研究,纳入2007-2011年美国大型透析机构的15,573例新发腹膜透析患者。
主要发现
- 较高BMI与更短转血液透析时间显著相关(趋势P<0.001)。
- 较高BMI与更长肾移植等待时间显著相关(趋势P<0.001)。
- 较高BMI与更频繁的腹膜炎相关住院呈边缘显著相关(趋势P=0.05)。
- 肥胖患者残余肾功能下降更快(趋势P<0.001),随时间达到的总Kt/V更低(趋势P<0.001)。
- BMI与死亡率呈U形关联,混合调整模型中BMI 30-<35 kg/m2生存最佳。
关键数值与推荐
- 与匹配血透患者相比,腹透患者在BMI<25和25-<35 kg/m2类别死亡率更低,在BMI≥35 kg/m2类别生存相当(交互作用P=0.001, vs <25 kg/m2)。
- 重度肥胖患者生存差异的减弱仅见于糖尿病患者,非糖尿病患者中未观察到此现象。
临床怎么用
- 肥胖不应视为腹膜透析的绝对禁忌,尤其糖尿病重度肥胖患者需个体化评估。
- 腹透肥胖患者应关注残余肾功能保护及腹膜炎预防。
局限性
- 无法评估因果关系。
- 可能存在指征偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevalence of severe obesity, often considered a contraindication to peritoneal dialysis (PD), has increased over time. However, mortality has decreased more rapidly in the PD population than the hemodialysis (HD) population in the United States. The association between obesity and clinical outcomes among patients with end-stage kidney disease remains unclear in the current era. STUDY DESIGN: Historical cohort study. SETTING & PARTICIPANTS: 15,573 incident PD patients from a large US dialysis organization (2007-2011). PREDICTOR: Body mass index (BMI). OUTCOMES: Modality longevity, residual renal creatinine clearance, peritonitis, and survival. RESULTS: Higher BMI was significantly associated with shorter time to transfer to HD therapy (P for trend < 0.001), longer time to kidney transplantation (P for trend < 0.001), and, with borderline significance, more frequent peritonitis-related hospitalization (P for trend = 0.05). Compared with lean patients, obese patients had faster declines in residual kidney function (P for trend < 0.001) and consistently achieved lower total Kt/V over time (P for trend < 0.001) despite greater increases in dialysis Kt/V (P for trend < 0.001). There was a U-shaped association between BMI and mortality, with the greatest survival associated with the BMI range of 30 to < 35kg/m2 in the case-mix adjusted model. Compared with matched HD patients, PD patients had lower mortality in the BMI categories of < 25 and 25 to < 35kg/m2 and had equivalent survival in the BMI category ≥ 35kg/m2 (P for interaction = 0.001 [vs < 25 kg/m2]). This attenuation in survival difference among patients with severe obesity was observed only in patients with diabetes, but not those without diabetes. LIMITATIONS: Inability to evaluate causal associations. Potential indication bias. CONCLUSIONS: Whereas obese PD patients had higher risk for complications than nonobese PD patients, their survival was no worse than matched HD patients.
引用
- Obi Y, Streja E, Mehrotra R, et al. Impact of Obesity on Modality Longevity, Residual Kidney Function, Peritonitis, and Survival Among Incident Peritoneal Dialysis Patients. Am J Kidney Dis. 2017. PMID: 29223620. doi:10.1053/j.ajkd.2017.09.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。